new_0222_0431|ABOS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0431|ABOS|1|Acumen Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Acumen Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Acumen Pharmaceuticals Inc Inventories (Quarterly) (USD)|Acumen Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Acumen Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Acumen Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Acumen Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Acumen Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Acumen Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Acumen Pharmaceuticals Inc Book Value (Quarterly) (USD)|Acumen Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Acumen Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Acumen Pharmaceuticals Inc EV to Revenues|Acumen Pharmaceuticals Inc EV to Earnings|Acumen Pharmaceuticals Inc EV to Free Cash Flow|Acumen Pharmaceuticals Inc EV to Assets (Quarterly)|Acumen Pharmaceuticals Inc PS Ratio|Acumen Pharmaceuticals Inc PE Ratio|Acumen Pharmaceuticals Inc Price to Book Value|Acumen Pharmaceuticals Inc PEG Ratio|Acumen Pharmaceuticals Inc Debt to Equity Ratio|Acumen Pharmaceuticals Inc Dividend Yield|Acumen Pharmaceuticals Inc Shareholder Yield (TTM)|Acumen Pharmaceuticals Inc Percent of Shares Outstanding Short|Acumen Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Acumen Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Acumen Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Acumen Pharmaceuticals Inc Return on Invested Capital|Acumen Pharmaceuticals Inc Quality Ratio Score|Acumen Pharmaceuticals Inc Momentum Score|Acumen Pharmaceuticals Inc Beta (1Y)|Acumen Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Acumen Pharmaceuticals Inc Institutional Investor Ownership Percentage|Acumen Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Acumen Pharmaceuticals Inc Total Employees (Annual)|Acumen Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Acumen Pharmaceuticals Inc Shares Outstanding|Acumen Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Acumen Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Acumen Pharmaceuticals Inc Payout Ratio|Acumen Pharmaceuticals Inc Quick Ratio (Quarterly)|Acumen Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Acumen Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Acumen Pharmaceuticals Inc Effective Tax Rate (TTM)|Acumen Pharmaceuticals Inc Return on Equity|Acumen Pharmaceuticals Inc Net Income (TTM) (USD)|Acumen Pharmaceuticals Inc Revenue (TTM) (USD)|Acumen Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Acumen Pharmaceuticals Inc Revenue (Quarterly) (USD)|Acumen Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Acumen Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Acumen Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Acumen Pharmaceuticals Inc Net Income (Quarterly) (USD)|Acumen Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Acumen Pharmaceuticals Inc Price (USD)|Acumen Pharmaceuticals Inc Total Return Price (USD)|Acumen Pharmaceuticals Inc Enterprise Value (USD)|Acumen Pharmaceuticals Inc 30-Day Average Daily Volume|Acumen Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_0222_0431|ABOS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0431|ABOS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0431|ABOS|5|91|91|0|92|0|91|91|91|0|91|91|0|1.44375|0|1.44375|0|1.44099378882|0|1.4387755102|0|0|1.44375|0|15.3846153846|91|91|91|0|0|0|0|0|30.6666666667|91.3333333333|0|91.3333333333|28.8|0|91|0|0|91.3333333333|91.25|0|0|91|0|0|91.6666666667|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44099378882|1.44099378882|1.44375|1.4427480916|0||
new_0222_0431|ABOS|6|3|3|0|1|0|3|3|3|0|3|3|0|160|0|160|0|161|0|98|0|0|160|0|13|3|3|3|0|0|0|0|0|6|6|0|6|5|0|3|0|0|6|4|0|0|3|0|0|3|0|6|6|6|6|161|161|160|131|0||
new_0222_0431|ABOS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0431|ABOS|202003||||||||||||||||||||||||||||||||||28.6518||-0.0714||||||-0.0714|||||||0.226||0.222|-2.045|-2.045|0.001|||||||
new_0222_0431|ABOS|202006||||||||||||||||||||||||||||||||||28.6518||-0.071||||||-0.071|||||||0.151||0.259|-2.035|-2.035|0|||||||
new_0222_0431|ABOS|202009||||||||||||||||||||||||||||||||||28.6518||-0.0869||||||-0.0869|0||||||0.73||0.226|-2.49|-2.49|0|||||||
new_0222_0431|ABOS|202012|44.429|43.777||||63.02|6.367|56.653||-18.591|-26.965||||||||||0||||0.109|0.531|0|||||||28.6518||-0.0264|||38.6518|0|6.8927|-0.0264||||-7.325|1.436||0.329||0.644|-0.755|-0.755|0|||||||
new_0222_0431|ABOS|202103|42.103|41.407||||87.835|31.182|56.653||-45.462|-53.962||||||||||||||0.109|0.918|0|||||||28.6518|7|-0.7299|||38.6518|||0.6803||||-32.277|||||1.215|-26.997|-26.997|0.004|||||||
new_0222_0431|ABOS|202106|70.572|68.812||0.006||179.022|4.518|174.504||-106.079|-115.32||384.9149||-51.3029||335.8146|||||0||0.0791|0.109|2.907|0||||||29.1873|38.6518||-1.659|36.9851||38.6518|||-0.16||||-91.6|||||1.187|-61.358|-61.358|0.004|15.48|15.48|513.3891|160216.0667||18.68|
new_0222_0431|ABOS|202109|204.913|199.964||0.013||1.489|1.489|0||233.36|-119.222||279.5436|-54.802|-23.3672|9.0352|347.2386||2.5771|||0||1.6751|0.109|0.382|0.004||||||77.1977|38.2666||-0.1|40.4703||40.4703|||-0.1|-168.559|||-93.012|||||2.135|-3.902|-3.902|0.014|16.14|16.14|526.0691|263622.0667||14.05|8.27
new_0222_0431|ABOS|202112||194.237||||5.147|||||||51.2641||-4.2852||157.9632||1.1533|||0||2.487|||||||||75.082|||-0.2063|40.4733||||||0.003|||-100.606|||||2.742||-8.349||6.83|6.83|69.1635|136853.1333||5.09|5.7
new_0222_0431|ABOS|202203||189.09||||3.998|||||||||||||0.7872|||||||||||||||||-0.23|40.4733|||||||||-82.738|||||3.221||-9.129||4.38|4.38|-16.9639|266918.0667||4|3.54
new_0222_0431|ABOS|202206||189.911||||5.159|||||||||||||0.8228|||||||||||||||||-0.25|40.5013|||||||||-31.531|||||3.09||-10.151||4.39|4.39|-11.2893|280749.7667||5.52|5.25
new_0222_0431|ABOS|202209||200.194||||6.613|||||||||||||0.9218|||||||||||||||||-0.26|40.5031|||||||||-38.339|||||3.062||-10.71||4.7|4.7|0.4536|2216775.6||7.27|5.84
new_0222_0431|ABOS|202212||177.605||||7.812|||||||||||||1.0551|||||||||||||||||-0.32|41.0251||||||-3.792|||-42.856|||||3.502||-12.866||5.07|5.07|7.2973|124433.0667||6.57|5.27
new_0222_0431|ABOS|202303||140.409||||8.779|||||||||||||0.8715|||||||||||||||||-0.28|41.0251|||||||||-45.034|||||4.422||-11.307||4.01|4.01|-13.0943|81836.4||3.66|4.94
new_0222_0431|ABOS|202306||144.881||||8.531|||||||||||||1.0927|||||||||||||||||-0.28|41.0251|||||||||-46.493|||||4.345||-11.61||4.77|4.77|55.2807|167330.8667||7.1|6.36
new_0222_0431|ABOS|202309||215.434||||6.098|||||||||||||1.4427|||||||||||||||||-0.24|57.9105||||||-122.294|||-48.74|||||4.86||-12.957||4.21|4.21|98.7454|346411||3.285|2.25
new_0222_0431|ABOS|202312||243.522||||43.152|||||||||||||0.7934|||||||||||||||||-0.29|57.9105||||||0.39|||-52.371|||||5.193||-16.497||3.84|3.84|6.9423|497210.3333||3.18|4.17
new_0222_0431|ABOS|202403||252.512||||38.933|||||||||||||0.9227|||||||||||||||||-0.25|60.0798||||||-7.906|||-55.937|||||5.325||-14.873||4.1|4.1|42.1581|419443.9||3.18|3.05
new_0222_0431|ABOS|202406||260.472||||44.966|||||||||||||0.5411|||||||||||||||||-0.34|60.0798|||||||||-64.864|||||4.848||-20.537||2.36|2.36|-96.3422|348295.1667||3.48|2.74
new_0222_0431|ABOS|202409||200.343||||49.773|||||||||||||0.6108|||||||||||||||||-0.5|60.0798|||||||||-81.672|||||5.018||-29.765||2.48|2.48|-86.0073|168976.7667||2.9|2.27
new_0222_0431|ABOS|202412||171.557||||57.176|||||||||||||0.4924|||||||||||||||||-0.62|60.0941||||||0.009|||-102.329|||||5.028||-37.154||1.78|1.78|-39.7461|335157.9||1.5|1.28
new_0222_0431|ABOS|202503||149.148||||48.957|||||||||||||0.3965|||||||||||||||||-0.48|60.5734||||||0.073|||-116.252|||||5.104||-28.796||1.19|1.19|-71.0257|208880.3333||1.1|1.05
new_0222_0431|ABOS|202506|||||||||||||||||||0.4362||||||||||||||||||||||||||||||||||||1.12|1.12|-44.0775|276131.2667||1.16|